← Evidence map

ArticleBiochemistry and biophysics reports2022

The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy.

Hiroto Yanagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36237446